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To the Editor,
Den Elzen et al. [1] reported on the interference of glucose 
and total protein in the Jaffe creatinine assays. Although 
this interference is well known (it was already noticed as 
early as 1886 by Jaffe himself) [2], we believe that the issue 
is more complex than depicted by den Elzen et al. [1].
It is generally accepted that plasma proteins consti-
tute the largest source of analytical error in the Jaffe-based 
methods. The so-called protein error produces a positive 
difference of ~27 μmol/L creatinine compared with refer-
ence methods [3]. However, when reducing the protein 
concentration in plasma, the covolume of the solutes is 
affected as well as density of plasma proteins is 1.3 kg/L 
and plasma proteins constitute more than 80% of the 
volume of solutes present in human plasma. In hypopro-
teinemia, the space lost by absence of plasma proteins is 
restored by extracellular water, containing the extracellu-
lar concentration of creatinine. In Jaffe-based creatinine 
assays, the apparent loss of protein due to the pseu-
dochromogen effect (±0.36 μmol creatinine/g protein) is 
partially counteracted by volume displacement. The net 
effect of this compensation will depend on the plasma cre-
atinine concentration.
Since the distribution volume of creatinine corre-
sponds to the total body water, even an ideal creatinine 
assay will measure an apparent increase in plasma creati-
nine due to the increased water content of the plasma in 
case of hypoproteinemia. As eGFR formulas are based on 
exponential functions, a water shift of 2.5% in a  Caucasian 
women aged 55 years with a creatinine concentration of 
93 μmol/L would result in an apparent increase of cre-
atinine concentration with 2.33 μmol/L, yielding a 3.3% 
decrease in eGFR. Thus, it is remarkable that this predict-
able effect on creatinine and eGFR has not been noticed 
by den Elzen et al. [1].
When dealing with extreme increases or reductions of 
plasma protein concentrations, attention should be paid 
to this covolume effect. In the real world, extreme values 
of protein concentrations are mainly observed in inten-
sive care ward patients. In these patients, however, eGFR 
measurements are often unreliable because of the instabil-
ity of the patient [4]. In case of hypoproteinemia, edema 
will occur, which strongly affects the distribution of cre-
atinine in the various body compartments, making eGFR 
calculation unreliable. Similarly, in case of extreme hyper-
glycemia, marked osmotic diuresis will occur, which will 
largely affect the total body water and hence disturb creati-
nine kinetics. In this case, an analytical correct creatinine 
result does not warrant a reliable eGFR value. The National 
Kidney Foundation argues against the use of eGFR formulas 
when renal function is not stable or in patients with serious 
comorbid conditions or malnutrition (which is clearly the 
case in life-threatening hyperglycemia and pronounced 
edema). The physiological limitations of creatinine as a fil-
tration marker have to be respected. All estimates of GFR 
based on serum creatinine will be less accurate for critically 
ill patients. Thus, in clinical practice, one should be aware 
that in conditions associated with extreme concentrations 
of pseudochromogens (e.g. glucose, total protein), calcula-
tion of eGFR remains risky. It should be noted that eGFR 
formulas [5] have been developed for assessing chronic 
kidney disease in the general population and not for adjust-
ing drug doses in intensive care wards. As in the critically 
ill, complete laboratory data sets are available, mathemati-
cal correction formulas for compensating analytical errors 
[6] can be applied confirmatory tests with exogenous meas-
ured GFR or measured creatinine clearance should be 
performed for people in whom estimates based on serum/
plasma creatinine alone may be inaccurate [4].
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